| Hukyndra 40 mg solution for injection in pre-filled syringe EU/1/21/1589/001-003 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Hukyndra 80 mg solution for injection in pre-filled pen EU/1/21/1589/008-009 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Hukyndra 80 mg solution for injection in pre-filled syringe EU/1/21/1589/007 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Hulio EU/1/18/1319/001-007 |
Adalimumab |
Biosimilar Collaborations Ireland Limited |
— |
| Hulio 20 mg solution for injection in pre-filled syringe EU/1/18/1319/009-010 |
Adalimumab |
Biosimilar Collaborations Ireland Limited |
— |
| Humalog EU/1/96/007/019 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Humalog 100 units/ml solution for injection in cartridge insulin lispro EU/1/96/007/004 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Humalog 100 units/ml solution for injection in vial EU/1/96/007/002 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Humalog 200 units/ml KwikPen solution for injection in a pre-filled pen EU/1/96/007/039-042 |
|
Eli Lilly and Company Limited |
— |
| Humalog Mix25 100 units/ml suspension for injection in cartridge EU/1/96/007/008 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Humalog Mix25 100 units/ml suspension for injection in vial EU/1/96/007/005 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Humalog Mix50 100 units/ml suspension for injection in cartridge EU/1/96/007/006 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Humalog NPL EU/1/96/007/010 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Humira 20 mg solution for injection in pre-filled syringe EU/1/03/256/022 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 40 mg/0.8 ml solution for injection EU/1/03/256/1-10 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 80 mg solution for injection in pre-filled syringe EU/1/03/256/020 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| HYCAMTIN 0.25 mg hard capsules EU/1/96/027/006 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| HYCAMTIN 1 mg hard capsules EU/1/96/027/007 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| Hycamtin 1 mg powder for concentrate for solution for infusion EU/1/96/027/004 |
Topotecan (as hydrochloride) |
Sandoz Pharmaceuticals d.d. |
— |
| HYCAMTIN 1 mg powder for concentrate for solution for infusion EU/1/96/027/005 |
Topotecan (as hydrochloride) |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Hycamtin 4 mg powder for concentrate for solution for infusion EU/1/96/027/003 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| HYCAMTIN 4 mg powder for concentrate for solution for infusion EU/1/96/027/001 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| Hydrex Surgical Scrub 4.0% w/v Cutaneous Solution PA1843/001/001 |
Chlorhexidine gluconate |
Ecolab Deutschland GmbH |
Marketed |
| Hydrocortisone 10 mg Tablets PA22865/003/001 |
Hydrocortisone |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Hydrocortisone 20 mg Tablets PA22865/003/002 |
Hydrocortisone |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Hydrocortisone 5 mg Tablets PA22865/003/003 |
Hydrocortisone |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Hydrocortisone Hualan 10 mg tablets PA23341/001/003 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| Hydrocortisone Hualan 15 mg tablets PA23341/001/004 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| Hydrocortisone Hualan 2.5 mg tablets PA23341/001/001 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| Hydrocortisone Hualan 20 mg tablets PA23341/001/005 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| Hydrocortisone Hualan 5 mg tablets PA23341/001/002 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| HYFTOR 2 mg/g Gel EU/1/23/1723/001 |
Sirolimus |
Plusultra Pharma GmbH |
— |
| Hympavzi 150 mg solution for injection in pre-filled pen EU/1/24/1874/002 |
Marstacimab |
Pfizer Europe MA EEIG |
— |
| Hympavzi 150 mg solution for injection in pre-filled syringe EU/1/24/1874/001 |
Marstacimab |
Pfizer Europe MA EEIG |
— |
| HyQvia 100 mg/mL solution for infusion for subcutaneous use EU/1/13/840/001-006 |
Human normal immunoglobulin |
Baxalta Innovations GmbH |
— |
| Hyrimoz 20 mg solution for injection in pre-filled syringe EU/1/18/1286/007 |
Adalimumab |
Sandoz GmbH |
— |
| Hyrimoz 40 mg solution for injection in pre-filled pen EU/1/18/1286/004-006 |
Adalimumab |
Sandoz GmbH |
— |
| Hyrimoz 40 mg solution for injection in pre-filled syringe EU/1/18/1286/001-003 |
Adalimumab |
Sandoz GmbH |
— |
| Hyrimoz 80 mg solution for injection in pre-filled pen EU/1/18/1286/010-011 |
Adalimumab |
Sandoz GmbH |
— |
| Hyrimoz 80 mg solution for injection in pre-filled syringe EU/1/18/1286/008-009 |
Adalimumab |
Sandoz GmbH |
— |
| Iasibon 1 mg concentrate for solution for infusion EU/1/10/659/003 |
Ibandronic acid |
Pharmathen S.A. |
— |
| Iasibon 2 mg concentrate for solution for infusion EU/1/10/659/004 |
Ibandronic acid |
Pharmathen S.A. |
— |
| Iasibon 50 mg film-coated tablets EU/1/10/659/001-002&8-10 |
Ibandronic acid |
Pharmathen S.A. |
— |
| Iasibon 6 mg concentrate for solution for infusion EU/1/10/659/005-007 |
Ibandronic acid |
Pharmathen S.A. |
— |
| Ibandronic acid Accord 2 mg concentrate for solution for infusion EU/1/12/798/001 |
Ibandronate sodium monohydrate |
Accord Healthcare S.L.U. |
— |
| Ibandronic acid Accord 3 mg solution for injection in pre-filled syringe EU/1/12/798/005-006 |
Ibandronic acid, Ibandronate sodium monohydrate, Ibandronate sodium |
Accord Healthcare S.L.U. |
— |
| Ibandronic acid Accord 6 mg concentrate for solution for infusion EU/1/12/798/002-004 |
Ibandronate sodium monohydrate |
Accord Healthcare S.L.U. |
— |
| Ibandronic Acid Sandoz 50 mg film-coated tablets EU/1/11/685/001-005 |
Ibandronic acid |
Sandoz GmbH |
— |
| Ibandronic Acid Teva 150 mg film-coated tablets EU/1/10/642/003-004 |
Ibandronic acid |
Teva Pharma B.V. |
— |
| Ibandronic Acid Teva 50 mg film-coated tablets EU/1/10/642/001-002 |
Ibandronic acid |
Teva Pharma B.V. |
— |